A global survey of potential acceptance of a COVID-19 vaccine
Open accessAbstract
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 48.1% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so. Survey data from across 19 countries reveal heterogeneity in attitudes toward acceptance of a COVID-19 vaccine and suggest that trust in government is associated with vaccine confidence.
AI snapshot
Written from the paper’s full text.
TL;DR
In June 2020, a 19-country survey of 13,426 adults found that 71.5% would be very or somewhat likely to take a COVID-19 vaccine, but only 48.1% would accept their employer’s recommendation to do so. Acceptance varied widely by country and was strongly associated with trust in government.
Key findings
- Overall, 71.5% reported they would take a proven safe and effective COVID-19 vaccine, and 48.1% said they would accept an employer recommendation to get vaccinated.
- Country variation was large: China had the highest positive response for the general vaccine question (631/712, 88.6%) and Russia the lowest (373/680, 54.9%); Poland had the highest negative response (182/666, 27.3%). For employer recommendation, China had 83.7% positive responses (596/712), while Russia had the lowest willingness (184/680, 27.1%) and highest negative response (278/680, 40.9%).
- Trust in government was associated with acceptance: OR = 1.67 (95% CI 1.54, 1.80) for the general vaccine question and OR = 4.35 (95% CI 4.01, 4.72) for the employer-recommendation question.
- Older age and higher income/education were positively associated with acceptance. For example, respondents aged 65+ vs 18–24 had OR = 1.73 (95% CI 1.48, 2.02) for the general question, and those earning >$32/day vs <$2/day had OR = 2.18 (95% CI 1.79, 2.64). Men were slightly less likely than women to respond positively (OR = 0.84; 95% CI 0.78, 0.91), and self/family COVID-19 sickness was not associated with acceptance (OR = 0.97; 95% CI 0.87, 1.08).
Methods
- The study analyzed two vaccine-acceptance questions from the COVID-SCORE online survey, collected June 16–20, 2020, from 13,426 respondents aged 18+ in 19 countries, with 619–773 participants per country.
- Participants were recruited through multiple international online panel providers; sampling was random and described elsewhere.
- Responses used a five-point Likert scale. Logistic regressions coded “completely agree” or “somewhat agree” as 1 and all other responses as 0, with univariate models against age, gender, income, education, COVID-19 sickness in self/family, country cases and mortality per million, and trust in government.
Limitations
- The paper states that public surveys are snapshots at a point in time, the survey occurred in a highly dynamic COVID-19 landscape, and reported willingness may not predict actual acceptance. It also notes that events after the survey may have increased hesitancy, and that employment status was not investigated for the age/employer-recommendation finding.
- The text makes evident that the regressions are univariate rather than multivariable-adjusted, so associations may not be independent.
- The online panel design may limit representativeness despite random sampling, and the outcomes are self-reported intentions rather than observed vaccination behavior.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 11 cited sources checked · 0 supported · 0 flagged
- Findingown data
Respondents who trusted their government were more likely to accept a vaccine than those who did not (OR = 1.67; 95% CI 1.54, 1.80).
“Respondents who said that they trusted their government were more likely to accept a vaccine than those who said that they did not (OR = 1.67; 95% CI (1.54, 1.80)).”
Quote in the paperSubstantial claim - Findingown data
Men were slightly less likely than women to respond positively to the general vaccine question, OR = 0.84 (95% CI 0.78, 0.91).
“Gender differences were small, but the univariate association for both questions suggested that men were slightly less likely to respond positively than women, with an OR of 0.84 (95% CI (0.78, 0.91)) of men responding positively relative to women for the general question”
Quote in the paperNot a substantial claim - Findingown data
Acceptance rates varied by country, ranging from almost 90% in China to less than 55% in Russia.
“Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia).”
Quote in the paperSubstantial claim - Findingown data
The difference in acceptance was strongest when the oldest age cohort (65+) was compared with the youngest (18-24), OR = 1.73 (95% CI 1.48, 2.02).
“This difference was strongest (odds ratio (OR) = 1.73; 95% confidence interval (CI) (1.48, 2.02)) when responses from the oldest age cohort and those from the youngest age cohort were compared (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
Poland reported the highest proportion of negative responses (27.3%, 182/666) to the proven safe and effective vaccine question.
“Respondents from Poland reported the highest proportion of negative responses (182 of 666, 27.3%)”
Quote in the paperNot a substantial claim
- Findingown data
48.1% of surveyed participants reported they would accept their employer's recommendation to take a COVID-19 vaccine.
“and 48.1% reported that they would accept their employer’s recommendation to do so.”
- Also stated in: § Discussion · hedged
“and 48.1% said that they would get vaccinated if their employer recommended it”
Quote in the paperSubstantial claim - Also stated in: § Discussion · hedged
- Findingown data
There was high heterogeneity in responses between countries.
“However, we observed high heterogeneity in responses between countries.”
Quote in the paperSubstantial claim - Findingown data
People aged 25-54, 55-64 and 65+ were more likely to accept the vaccine than those aged 18-24.
“People aged 25–54, 55–64 and 65+ were more likely to accept the vaccine than those who were aged 18–24.”
Quote in the paperNot a substantial claim - Findingown data
Men were slightly less likely than women to respond positively to the employer recommendation question, OR = 0.93 (95% CI 0.87, 1.00).
“and an OR of 0.93 (95% CI (0.87, 1.00)) for the business-related question.”
Quote in the paperNot a substantial claim - Findingown data
Russia gave the lowest proportion of positive responses (54.9%, 373/680) to the proven safe and effective vaccine question.
“whereas Russian respondents gave the lowest proportion of positive responses (373 of 680, 54.9%).”
Quote in the paperNot a substantial claim - Findingown data
If an individual trusted their government, they were more likely to respond positively to their employer's vaccine recommendation than someone who did not (OR = 4.35; 95% CI 4.01, 4.72).
“Moreover, if an individual trusted their government, they were more likely to respond positively to their employer’s vaccine recommendation than someone who did not (OR = 4.35; 95% CI (4.01, 4.72)) (Table 2).”
Quote in the paperNot a substantial claim - Findingown data
Higher levels of education were positively associated with vaccine acceptance on both questions.
“Higher levels of education were also associated positively with vaccine acceptance on both questions.”
Quote in the paperNot a substantial claim - Findingown data
People earning more than $32 per day were 2.18 times more likely to respond positively to the general vaccine question than people earning less than $2 per day (95% CI 1.79, 2.64).
“People earning more than $32 per day were 2.18 (95 CI% (1.79, 2.64)) times more likely to respond positively to the general question than people earning less than $2 per day.”
Quote in the paperSubstantial claim - Findingown data
People who reported COVID-19 sickness in themselves or family members were no more likely to respond positively to the vaccine question than other respondents (OR = 0.97; 95% CI 0.87, 1.08).
“People who reported COVID-19 sickness in themselves or family members were no more likely to respond positively to the vaccine question than other respondents (OR = 0.97; 95% CI (0.87, 1.08)).”
Quote in the paperNot a substantial claim - Findingown data
Countries where acceptance exceeded 80% tended to be Asian nations with strong trust in central governments (China, South Korea and Singapore).
“Countries where acceptance exceeded 80% tended to be Asian nations with strong trust in central governments (China, South Korea and Singapore).”
Quote in the paperNot a substantial claim - Findingown data
A relatively high tendency toward acceptance was observed in middle-income countries such as Brazil, India and South Africa.
“A relatively high tendency toward acceptance in middle-income countries, such as Brazil, India and South Africa, was also observed.”
Quote in the paperNot a substantial claim - Findingown data
All respondents, regardless of nationality, reported they would be less likely to accept a COVID-19 vaccine if it were mandated by employers.
“All respondents, regardless of nationality, reported that they would be less likely to accept a COVID-19 vaccine if it were mandated by employers.”
Quote in the paperSubstantial claim - Findingnone given
Univariate variation among demographically defined groups was least among those with lower education and income levels.
“Univariate variation among demographically defined groups was least among those with lower education and income levels.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Unless the origins of wide variation in willingness to accept a COVID-19 vaccine are better understood and addressed, differences in vaccine coverage between countries could potentially delay global control of the pandemic and the ensuing societal and economic recovery.
“Unless and until the origins of such wide variation in willingness to accept a COVID-19 vaccine is better understood and addressed, differences in vaccine coverage between countries could potentially delay global control of the pandemic and the ensuing societal and economic recovery.”
Quote in the paperNot a substantial claim - Interpretationown data
In most of the 19 countries surveyed, current levels of willingness to accept a COVID-19 vaccine are insufficient to meet the requirements for community immunity.
“In most of the 19 countries surveyed in our study, current levels of willingness to accept a COVID-19 vaccine are insufficient to meet the requirements for community immunity.”
Quote in the paperSubstantial claim- Rests on an assumption: The level of vaccine acceptance required for community immunity is higher than the levels of willingness observed in most of the 19 countries.
- Interpretationown data
Trust in government can contribute to public compliance with recommended actions.
“Our findings show that trust in government is strongly associated with vaccine acceptance and can contribute to public compliance with recommended actions15.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [15] Hovland, C. I. & Weiss, W. The influence of source credibility on communication effectiveness. Public Opin. Q. 15, 635 (1951). source
Not checked in the free run.
- Interpretationown data
Trust is an intrinsic and potentially modifiable component of successful uptake of a COVID-19 vaccine.
“Arguably, trust is an intrinsic and potentially modifiable component of successful uptake of a COVID-19 vaccine.”
Quote in the paperSubstantial claim - Premisecitation
Subsequent national surveys in the United States and elsewhere have suggested strongly that public hesitancy to a COVID-19 vaccine is now greater than that reported in this study.
“subsequent national surveys in the United States and elsewhere have suggested strongly that public hesitancy to a COVID-19 vaccine is now greater than that which we report here”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites https://www.kff.org/coronavirus-covid-19/press-release/poll-most-americans-worry-political-pressure-will-lead-to-premature-approval-of-a-covid-19-vaccine-half-say-they-would-not-get-a-free-vaccine-approved-before-election-day/
Not checked in the free run.
- Premisecitation
In many countries, vaccine hesitancy and misinformation present substantial obstacles to achieving coverage and community immunity.
“In many countries, vaccine hesitancy and misinformation present substantial obstacles to achieving coverage and community immunity5,6.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [5] Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D. & Paterson, P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine 32, 2150–2159 (2014). source
Not checked in the free run.
- cites [6] Lane, S., MacDonald, N. E., Marti, M. & Dumolard, L. Vaccine hesitancy around the globe: analysis of three years of WHO/UNICEF Joint Reporting Form data—2015–2017. Vaccine 36, 3861–3867 (2018). source
Not checked in the free run.
- Study design and conductcitation
The survey respondents were a random sample of the populations of the 19 countries surveyed.
“Survey respondents represented a random sample of the populations of 19 countries that comprise around 55% of the global population.”
- Also stated in: § Study participants · plain
“Sampling was random and is described in detail elsewhere21.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] Lazarus, J. V. et al. COVID-SCORE: a global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10). PLoS ONE 15, e0240011 (2020). source
Not checked in the free run.
- Also stated in: § Study participants · plain
- May combine two claims. 7
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 11
May combine two claims.
Findingown dataFor the employer recommendation question, 14.0% completely agreed and 25.9% somewhat or completely disagreed.
“When asked whether “You would accept a vaccine if it were recommended by your employer and was approved safe and effective by the government,” 14.0% (1,881 of 13,426) completely agreed, whereas 25.9% (3,478 of 13,426) somewhat or completely disagreed (Table 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChina had the highest proportion of positive responses (88.6%, 631/712) and the lowest proportion of negative responses (0.7%, 5/712) when asked if they would take a proven, safe and effective vaccine.
“Respondents from China gave the highest proportion of positive responses (631 of 712 respondants, 88.6%) and the lowest proportion of negative responses (5 of 712, 0.7%) when asked if they would take a ‘proven, safe and effective vaccine’.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFor employer recommendation, the age trend was similar except that responses from the oldest age cohort were similar to the youngest age cohort.
“A similar trend was observed in regard to acceptance of the vaccine if one’s employer required it, except that responses from the oldest age cohort were similar to the youngest age cohort.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataRussia had the highest proportion of negative responses (40.9%, 278/680) and the lowest proportion willing to accept their employer's recommendation (27.1%, 184/680).
“Russia had the highest proportion of negative responses (278 of 680, 40.9%) and the lowest proportion of respondents (184 of 680, 27.1%) willing to accept their employer’s recommendation (Supplementary Table 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChina had the highest proportion of positive responses (83.7%, 596/712) and the lowest proportion of negative responses (3.7%, 26/712) to the employer recommendation question.
“There was considerable variation by country, with China again having the highest proportion of positive responses (596 of 712, 83.7%) and the lowest proportion of negative responses (26 of 712, 3.7%).”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataIn June 2020, 71.5% of 13,426 surveyed participants in 19 countries reported they would be very or somewhat likely to take a COVID-19 vaccine if it were proven safe and effective and available.
“Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine”
- Also stated in: § Discussion · plain
“Of these, 71.5% responded that they would take a vaccine if it were proven safe and effective”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNo personally identifiable information was collected or stored.
“No personally identifiable information was collected or stored.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMisinformation spread through multiple channels could have a considerable effect on the acceptance of a COVID-19 vaccine.
“Misinformation spread through multiple channels could have a considerable effect on the acceptance of a COVID-19 vaccine8.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Cornwall, W. Officials gird for a war on vaccine misinformation. Science 369, 14–19 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationAnti-vaccination activists are already campaigning in multiple countries against the need for a vaccine, with some denying the existence of COVID-19 altogether.
“Anti-vaccination activists are already campaigning in multiple countries against the need for a vaccine, with some denying the existence of COVID-19 altogether7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Enserink, M. & Cohen, J. Fact-checking Judy Mikovits, the controversial virologist attacking Anthony Fauci in a viral conspiracy video. Science https://www.sciencemag.org/news/2020/05/fact-checking-judy-mikovits-controversial-virologist-attacking-anthony-fauci-viral (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenRespondents' identities were verified using IP addresses and mobile phone numbers to ensure each participant was real and unique upon initial registration.
“Respondents’ identities were verified using IP addresses and mobile phone numbers to ensure that each participant was real and unique upon initial registration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study was approved by Emerson College institutional review board (protocol no. 20-023-F-E-6/12).
“This study was approved by Emerson College, USA (institutional review board protocol no. 20–023-F-E-6/12), with an expiration date of June 11, 2021.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThis particular survey was conducted in a highly dynamic and changing landscape, with daily variations in perceived disease threat and COVID-19 vaccine development itself.
“This particular survey was conducted in the context of a highly dynamic and changing landscape, with daily variations in perceived disease threat and COVID-19 vaccine development itself.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
InterpretationreasoningReporting one's willingness to get vaccinated might not be a good predictor of acceptance, as vaccine decisions are multifactorial and can change over time.
“Furthermore, reporting one’s willingness to get vaccinated might not be necessarily a good predictor of acceptance, as vaccine decisions are multifactorial and can change over time.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe accelerated pace of vaccine development has heightened public anxieties and could compromise acceptance.
“The accelerated pace of vaccine development has further heightened public anxieties and could compromise acceptance9.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] Fadda, M., Albanese, E. & Suggs, L. S. When a COVID-19 vaccine is ready, will we all be ready for it? Int. J. Public Health 65, 711–712 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLessons learned from previous infectious disease outbreaks and public health emergencies, including HIV, H1N1, SARS, MERS and Ebola, indicate that trusted sources of information and guidance are fundamental to disease control.
“Lessons learned from previous infectious disease outbreaks and public health emergencies, including HIV, H1N1, SARS, MERS and Ebola, remind us that trusted sources of information and guidance are fundamental to disease control16.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Siegrist, M. & Zingg, A. The role of public trust during pandemics: implications for crisis communication. Eur. Psychol. 19, 23–32 (2014). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationResearchers have identified promising interventions for building confidence and reducing vaccine hesitancy in different contexts.
“Researchers have identified promising interventions for building confidence and reducing vaccine hesitancy in different contexts12,13”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [12] Thomson, A., Vallée-Tourangeau, G. & Suggs, L. S. Strategies to increase vaccine acceptance and uptake: from behavioral insights to context-specific, culturally-appropriate, evidence-based communications and interventions. Vaccine 36, 6457–6458 (2018). source
Not checked in the free run.
- cites [13] European Centre for Disease Prevention and Control. Catalogue of interventions addressing vaccine hesitancy. https://www.ecdc.europa.eu/sites/portal/files/documents/Catalogue-interventions-vaccine-hesitancy.pdf (2017).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenAll public surveys of the type reported here are snapshots taken at a point in time.
“It must be kept in mind that all public surveys of the type reported here are snapshots taken at a point in time.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataWritten informed consent was obtained from respondents.
“The online questionnaire was administered by Emerson College to gather information from respondents after obtaining their written, informed consent about the survey and this project.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
The level of vaccine acceptance required for community immunity is higher than the levels of willingness observed in most of the 19 countries.
“In most of the 19 countries surveyed in our study, current levels of willingness to accept a COVID-19 vaccine are insufficient to meet the requirements for community immunity.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The heterogeneity analysis reported in Fig. 5 was not pre-specified and followed heterogeneity tests common in the vaccine literature.
“The heterogeneity analysis reported in Fig. 5, in which we analysed whether vaccination rates differ by age, sex, schooling and wealth variables, was not pre-specified and followed heterogeneity tests that are common in the vaccine literature54.”
From Last-mile delivery increases vaccine uptake in Sierra Leone (2024) · cites this paper as [54]
Information from employers and government sources has been shown to improve COVID-19 vaccine acceptance rates.
“For COVID-19, information from employers and government sources has been shown to improve vaccine acceptance rates, which range from 55% to 90% around the world244.”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [244]
COVID-19 vaccine acceptance rates range from 55% to 90% around the world.
“For COVID-19, information from employers and government sources has been shown to improve vaccine acceptance rates, which range from 55% to 90% around the world244.”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [244]
Cites
Vaccine hesitancy: Definition, scope and determinants
MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.036 · Cited by 5,573 · see citing works
The Influence of Source Credibility on Communication Effectiveness
Hovland, C. I., & Weiss, W. (1951) · Public Opinion Quarterly · doi:10.1086/266350 · Cited by 3,543 · see citing works
Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D., & Paterson, P. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.081 · Cited by 2,254 · see citing works
Self-citationMeasuring trust in vaccination: A systematic review
Larson, H. J., Clarke, R. M., Jarrett, C., Eckersberger, E., Levine, Z., Schulz, W. S., & Paterson, P. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1459252 · Cited by 789 · see citing works
Self-citationLane, S., MacDonald, N. E., Marti, M., & Dumolard, L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.063 · Cited by 530 · see citing works
The Role of Public Trust During Pandemics: Implications for Crisis Communication
Siegrist, M., & Zingg, A. (2014) · European Psychologist · doi:10.1027/1016-9040/a000169 · Cited by 420 · see citing works
Karafillakis, E., & Larson, H. J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.061 · Cited by 301 · see citing works
Self-citationQuinn, S. C., Parmer, J., Freimuth, V. S., Hilyard, K. M., Musa, D., & Kim, K. H. (2013) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2012.0048 · Cited by 235 · see citing works
Lazarus, J. V., Ratzan, S., Palayew, A., Billari, F. C., Binagwaho, A., Kimball, S., Larson, H. J., Melegaro, A., Rabin, K., White, T. M., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240011 · Cited by 232 · see citing works
Self-citationExposing concerns about vaccination in low- and middle-income countries: a systematic review
Muñoz, D. C., Llamas, L. M., & Bosch‐Capblanch, X. (2015) · International Journal of Public Health · doi:10.1007/s00038-015-0715-6 · Cited by 160 · see citing works
The Russian vaccine for COVID-19
Burki, T. K. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30402-1 · Cited by 140 · see citing works
When a COVID-19 vaccine is ready, will we all be ready for it?
Fadda, M., Albanese, E., & Suggs, L. S. (2020) · International Journal of Public Health · doi:10.1007/s00038-020-01404-4 · Cited by 138 · see citing works
Vaccine hesitancy and health literacy
Biasio, L. R. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1243633 · Cited by 133 · see citing works
Officials gird for a war on vaccine misinformation
Cornwall, W. (2020) · Science · doi:10.1126/science.369.6499.14 · Cited by 119 · see citing works
Thomson, A., Vallée-Tourangeau, G., & Suggs, L. S. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.08.031 · Cited by 74 · see citing works
Communicating in Times of Uncertainty: The Need for Trust
Shore, D. A. (2003) · Journal of Health Communication · doi:10.1080/713851977 · Cited by 64 · see citing works
Will carrots or sticks raise influenza immunization rates of health care personnel?
Lugo, N. R. (2007) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.10.004 · Cited by 56 · see citing works
Enserink, M. (2020) · Science · doi:10.1126/science.abc7103 · Cited by 45 · see citing works
Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigated
Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m3525 · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128 · see citing works
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works
Wouters, O. J., Shadlen, K. C., Salcher‐Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00306-8 · Cited by 1,291 · see citing works
Self-citationCOVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment
Khubchandani, J., SHARMA, S. K., Price, J. H., Wiblishauser, M. J., Sharma, M., & Webb, F. J. (2021) · Journal of Community Health · doi:10.1007/s10900-020-00958-x · Cited by 1,080 · see citing works
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review
Lin, C., Tu, P., & Beitsch, L. M. (2020) · Vaccines · doi:10.3390/vaccines9010016 · Cited by 832 · see citing works
Schwarzinger, M., Watson, V., Arwidson, P., Alla, F., & Luchini, S. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00012-8 · Cited by 765 · see citing works
Factors Associated with COVID-19 Vaccine Hesitancy
Soares, P., Rocha, J. V., Moniz, M., Gama, A. F., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021) · Vaccines · doi:10.3390/vaccines9030300 · Cited by 700 · see citing works
Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. (2021) · Vaccines · doi:10.3390/vaccines9010042 · Cited by 675 · see citing works
The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers
Biswas, N., Mustapha, T. A., Khubchandani, J., & Price, J. H. (2021) · Journal of Community Health · doi:10.1007/s10900-021-00984-3 · Cited by 594 · see citing works
Looking beyond COVID-19 vaccine phase 3 trials
Kim, J. H., Marks, F., & Clemens, J. D. (2021) · Nature Medicine · doi:10.1038/s41591-021-01230-y · Cited by 586 · see citing works
Wong, M. C. S., Wong, E. L., Huang, J., Cheung, A. W.-L., Law, K. M., Chong, K. C., Ng, R. W. Y., Lai, C. K. C., Boon, S. S., Lau, J. T. F., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.12.083 · Cited by 578 · see citing works
Skjefte, M., Ngirbabul, M., Akeju, O., Escudero, D. J., Hernández–Dı́az, S., Wyszynski, D. F., & Wu, J. W. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00728-6 · Cited by 563 · see citing works
Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan
El‐Elimat, T., AbuAlSamen, M. M., Almomani, B. A., Al‐Sawalha, N. A., & Alali, F. Q. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250555 · Cited by 551 · see citing works
Robinson, E., Jones, A., McFarland‐Lesser, I., & Daly, M. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.02.005 · Cited by 511 · see citing works
Behavioural nudges increase COVID-19 vaccinations
Dai, H., Saccardo, S., Han, M. A., Roh, L., Raja, N., Vangala, S., Modi, H., Pandya, S., Sloyan, M., & Croymans, D. M. (2021) · Nature · doi:10.1038/s41586-021-03843-2 · Cited by 462 · see citing works
A Comprehensive Review of mRNA Vaccines
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457 · see citing works
Saied, S. M., Saied, E. M., Kabbash, I., & Abdo, S. A. E. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26910 · Cited by 456 · see citing works
A survey of COVID-19 vaccine acceptance across 23 countries in 2022
Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Gostin, L. O., Larson, H. J., Rabin, K. H., Ratzan, S. C., Kamarulzaman, A., & El-Mohandes, A. A. E. (2023) · Nature Medicine · doi:10.1038/s41591-022-02185-4 · Cited by 450 · see citing works
Self-citationRevisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021
Lazarus, J. V., Wyka, K., White, T. M., Picchio, C. A., Rabin, K. H., Ratzan, S. C., Leigh, J. P., Hu, J., & El-Mohandes, A. A. E. (2022) · Nature Communications · doi:10.1038/s41467-022-31441-x · Cited by 448 · see citing works
Self-citationMaintaining safety with SARS-CoV-2 vaccines
Castells, M. C., & Phillips, E. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2035343 · Cited by 395 · see citing works
Verger, P., Scronias, D., Dauby, N., Adedzi, K. A., Gobert, C., Bergeat, M., Gagneur, A., & Dubé, È. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.3.2002047 · Cited by 392 · see citing works
Cascini, F., Pantović, A., Al‐Ajlouni, Y. A., Failla, G., & Ricciardi, W. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101113 · Cited by 392 · see citing works
Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective
Latkin, C. A., Dayton, L., Yi, G. T., Konstantopoulos, A. D., & Boodram, B. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113684 · Cited by 383 · see citing works
Watad, ., Marco, G. D., Mahajna, H., Druyan, A., Eltity, M., Hijazi, N., Haddad, A., Elias, M., Zisman, D., Naffaa, M. E., et al. (2021) · Vaccines · doi:10.3390/vaccines9050435 · Cited by 364 · see citing works
Antimicrobial resistance and COVID-19: Intersections and implications
Knight, G. M., Glover, R. E., McQuaid, C. F., Olaru, I. D., Gallandat, K., Leclerc, Q. J., Fuller, N. M., Willcocks, S., Hasan, R., van Kleef, E., et al. (2021) · eLife · doi:10.7554/elife.64139 · Cited by 361 · see citing works
Myths and conspiracy theories on vaccines and COVID-19: Potential effect on global vaccine refusals
Ullah, I., Khan, K. S., Tahir, M. J., Ahmed, A., & Harapan, H. (2021) · Vacunas · doi:10.1016/j.vacun.2021.01.001 · Cited by 359 · see citing works
Bono, S. A., Villela, E. F. D. M., Siau, C. S., Chen, W. S., Pengpid, S., Hasan, M. T., Sessou, P., Ditekemena, J., Amodan, B. O., Hosseinipour, M. C., et al. (2021) · Vaccines · doi:10.3390/vaccines9050515 · Cited by 350 · see citing works
Stone, C. A., Liu, Y., Relling, M. V., Krantz, M. S., Pratt, A. L., Abreo, A. M., Hemler, J. A., & Phillips, E. J. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.12.003 · Cited by 349 · see citing works
Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review
Joshi, A., Kaur, M., Kaur, R., Grover, A., Nash, D., & El-Mohandes, A. A. E. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.698111 · Cited by 349 · see citing works
Self-citationBardosh, K., de Figueiredo, A., Gur‐Arie, R., Jamrozik, E., Doidge, J., Lemmens, T., Keshavjee, S. A., Graham, J., & Baral, S. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008684 · Cited by 342 · see citing works
Lindholt, M. F., Jørgensen, F. J., Bor, A., & Petersen, M. B. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048172 · Cited by 334 · see citing works
Trust in science, social consensus and vaccine confidence
Sturgis, P., Brunton‐Smith, I., & Jackson, J. (2021) · Nature Human Behaviour · doi:10.1038/s41562-021-01115-7 · Cited by 318 · see citing works
Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
Wiysonge, C. S., Ndwandwe, D. E., Ryan, J., Jaca, A., Oumarou, B., Anya, B.-P. M., & Cooper, S. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1893062 · Cited by 307 · see citing works
Wang, Q., Yang, L., Jin, H., & Lin, L. K. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106694 · Cited by 293 · see citing works
Hussain, A., Tahir, A., Hussain, Z., Sheikh, Z., Gogate, M., Dashtipour, K. K., Ali, A., & Sheikh, A. (2021) · Journal of Medical Internet Research · doi:10.2196/26627 · Cited by 288 · see citing works
Lockyer, B., Islam, S., Rahman, A., Dickerson, J., Pickett, K., Sheldon, T., Wright, J., McEachan, R., Sheard, L., & the Bradford Institute for Health Research Covid‐19 Scientific Advisory Group (2021) · Health Expectations · doi:10.1111/hex.13240 · Cited by 281 · see citing works
Islam, M. S., Siddique, A. B., Akter, R., Tasnim, R., Sujan, M. S. H., Ward, P., & Sikder, M. T. (2021) · BMC Public Health · doi:10.1186/s12889-021-11880-9 · Cited by 279 · see citing works
COVID‐19 vaccination intention in the first year of the pandemic: A systematic review
Al-Amer, R. M., Maneze, D., Everett, B., Montayre, J., Villarosa, A. R., Dwekat, E., & Salamonson, Y. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.15951 · Cited by 278 · see citing works
Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic
Machida, M., Nakamura, I., Kojima, T., Saito, R., Nakaya, T., Hanibuchi, T., Takamiya, T., Odagiri, Y., Fukushima, N., Kikuchi, H., et al. (2021) · Vaccines · doi:10.3390/vaccines9030210 · Cited by 274 · see citing works
Wang, K., Wong, E. L., Ho, K., Cheung, A. W.-L., Yau, P. S.-Y., Dong, D., Wong, S. Y. S., & Yeoh, E. (2021) · Vaccines · doi:10.3390/vaccines9010062 · Cited by 270 · see citing works
COVID-19 Vaccination Acceptance and Its Associated Factors Among a Middle Eastern Population
Al-Qerem, W. A., & Jarab, A. S. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.632914 · Cited by 267 · see citing works
Alqudeimat, Y., Alenezi, D., AlHajri, B., Alfouzan, H., Almokhaizeem, Z., Altamimi, S., Almansouri, W., Alzalzalah, S., & Ziyab, A. H. (2021) · Medical Principles and Practice · doi:10.1159/000514636 · Cited by 266 · see citing works
Zintel, S., Flock, C., Arbogast, A. L., Forster, A. S., von Wagner, C., & Sieverding, M. (2021) · Journal of Public Health · doi:10.1007/s10389-021-01677-w · Cited by 263 · see citing works
Acceptance of a Covid-19 vaccine is associated with ability to detect fake news and health literacy
Montagni, I., Touhami, K. O., Mebarki, A., Texier, N., Schück, S., Tzourio, C., & the CONFINS group (2021) · Journal of Public Health · doi:10.1093/pubmed/fdab028 · Cited by 261 · see citing works
Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine
Cordina, M., Lauri, M. A., & Lauri, J. (2021) · Pharmacy Practice · doi:10.18549/pharmpract.2021.1.2317 · Cited by 261 · see citing works
Trent, M. J., Seale, H., Chughtai, A. A., Salmon, D. A., & MacIntyre, C. R. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.06.048 · Cited by 260 · see citing works
Mercadante, A. R., & Law, A. V. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.12.012 · Cited by 248 · see citing works
Lazarus, J. V., Wyka, K., Rauh, L. D., Rabin, K. H., Ratzan, S. C., Gostin, L. O., Larson, H. J., & El-Mohandes, A. A. E. (2020) · Journal of Health Communication · doi:10.1080/10810730.2020.1868630 · Cited by 247 · see citing works
Self-citationCrawshaw, A. F., Farah, Y., Deal, A., Rustage, K., Hayward, S. E., Carter, J., Knights, F., Goldsmith, L. P., Campos-Matos, I., Wurie, F. B., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00066-4 · Cited by 242 · see citing works
Knowledge, acceptance and perception on COVID-19 vaccine among Malaysians: A web-based survey
Mohamed, N. A., Solehan, H. M., Rani, M. D. M., Ithnin, M., & Isahak, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256110 · Cited by 233 · see citing works
A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review
Sallam, M., Alsanafi, M., & Sallam, M. (2022) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s347669 · Cited by 233 · see citing works
Abedin, M., Islam, M. A., Rahman, F. N., Reza, H. M., Hossain, M. Z., Hossain, M. A., Arefin, A., & Hossain, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250495 · Cited by 231 · see citing works
Wake, A. D. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s311074 · Cited by 231 · see citing works
A survey on COVID-19 vaccine acceptance and concern among Malaysians
Alwi, S. A. R. S., Elias, R., Arabi, Z., Omar, J., Brohi, I. B., & Lukas, S. B. (2021) · BMC Public Health · doi:10.1186/s12889-021-11071-6 · Cited by 230 · see citing works
Petersen, M. B., Bor, A., Jørgensen, F. J., & Lindholt, M. F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2024597118 · Cited by 227 · see citing works
Elhadi, M., Alsoufi, A., Alhadi, A., Hmeida, A., Alshareea, E. A. A., Dokali, M., Abodabos, S., Alsadiq, O., Abdelkabir, M., Ashini, A., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10987-3 · Cited by 226 · see citing works
A multinational Delphi consensus to end the COVID-19 public health threat
Lazarus, J. V., Romero, D., Kopka, C. J., Karim, S. A., Abu-Raddad, L. J., Almeida, G., Baptista-Leite, R., Barocas, J. A., Barreto, M. L., Bar-Yam, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-05398-2 · Cited by 226 · see citing works
Self-citationThe COVID-19 vaccines rush: participatory community engagement matters more than ever
Burgess, R. A., Osborne, R. H., Yongabi, K. A., Greenhalgh, T., Gurdasani, D., Kang, G., Falade, A. G., Odone, A., Busse, R., Martin-Moreno, J. M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32642-8 · Cited by 216 · see citing works
Daly, M., & Robinson, E. (2021) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.01.008 · Cited by 213 · see citing works
Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review
Roy, D. N., Biswas, M., Islam, M. E., & Azam, M. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265496 · Cited by 208 · see citing works
Maaravi, Y., Levy, A., Gur, T., Confino, D., & Segal, S. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.627559 · Cited by 205 · see citing works
Sallam, M., Dababseh, D., Eid, H., Hasan, H., Taim, D., Al-Mahzoum, K., Al-Haidar, A., Yaseen, A. I. B., Ababneh, N. A., Assaf, A. M., et al. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052407 · Cited by 201 · see citing works
A Scoping Review to Find Out Worldwide COVID-19 Vaccine Hesitancy and Its Underlying Determinants
Biswas, M. R., Alzubaidi, M. S., Shah, U., Abd-Alrazaq, A. A., & Shah, Z. (2021) · Vaccines · doi:10.3390/vaccines9111243 · Cited by 194 · see citing works
Tao, L., Wang, R., Han, N., Liu, J., Yuan, C., Deng, L., Han, C., Sun, F., Liu, M., & Liu, J. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1892432 · Cited by 191 · see citing works
Hossain, M. B., Alam, M. Z., Islam, M. S., Sultan, S., Faysal, M. M., Rima, S., Hossain, M. A., & Mamun, A. A. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.711066 · Cited by 191 · see citing works
Hou, Z., Tong, Y., Du, F., Lu, L., Zhao, S., Yu, K., Piatek, S. J., Larson, H. J., & Lin, L. K. (2021) · Journal of Medical Internet Research · doi:10.2196/27632 · Cited by 189 · see citing works
Self-citationPredictors of willingness to get a COVID-19 vaccine in the U.S
Kelly, B., Southwell, B. G., Mccormack, L. A., Bann, C., MacDonald, P. D. M., Frasier, A. M., Bevc, C. A., Brewer, N. T., & Squiers, L. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06023-9 · Cited by 187 · see citing works
Aga, Q. A. A. K., Alkhaffaf, W. H., Hatem, T. H., Nassir, K. F., Batineh, Y., Dahham, A. T., Shaban, D., Aga, L. A. A. K., Agha, M. Y. R., & Traqchi, M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27214 · Cited by 181 · see citing works
Rocard, E., Sillitti, P., & Nozal, A. L. (2021) · OECD health working papers · doi:10.1787/b966f837-en · Cited by 181 · see citing works
Chew, N., Cheong, C., Kong, G., Phua, K., Ngiam, J. N., Tan, B. Y., Wang, B., Hao, F., Tan, W., Han, X., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.069 · Cited by 177 · see citing works
Gennaro, F. D., Murri, R., Segala, F. V., Cerruti, L., Abdulle, A., Saracino, A., Bavaro, D. F., & Fantoni, M. (2021) · Viruses · doi:10.3390/v13030371 · Cited by 174 · see citing works
Al‐Metwali, B. Z., Al‐Jumaili, A. A., Al‐Alag, Z. A., & Sorofman, B. A. (2021) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13581 · Cited by 174 · see citing works
Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors
Shakeel, C. S., Mujeeb, A. A., Mirza, M. S., Chaudhry, B. M., & Khan, S. J. (2022) · Vaccines · doi:10.3390/vaccines10010110 · Cited by 173 · see citing works
Flattening the Curve of COVID-19 Vaccine Rejection—A Global Overview
Feleszko, W., Lewulis, P., Czarnecki, A., & Waszkiewicz, P. (2020) · Vaccines · doi:10.3390/vaccines9010044 · Cited by 170 · see citing works
COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity
Steinert, J., Sternberg, H., Prince, H., Fasolo, B., Galizzi, M. M., Büthe, T., & Veltri, G. (2022) · Science Advances · doi:10.1126/sciadv.abm9825 · Cited by 170 · see citing works
Worldwide Vaccination Willingness for COVID-19: A Systematic Review and Meta-Analysis
Nehal, K. R., Steendam, L. M., Ponce, M. C., van der Hoeven, M., & Smit, G. S. A. (2021) · Vaccines · doi:10.3390/vaccines9101071 · Cited by 166 · see citing works
Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
So, A. D., & Woo, J. (2020) · BMJ · doi:10.1136/bmj.m4750 · Cited by 164 · see citing works
Đorđević, J. M., Mari, S., Vdović, M., & Milošević, A. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113930 · Cited by 164 · see citing works
Urrunaga‐Pastor, D., Bendezú-Quispe, G., Herrera‐Añazco, P., Uyen‐Cateriano, A., Toro-Huamanchumo, C. J., Rodriguez-Morales, A. J., Hernández, A. V., & Benites-Zapata, V. A. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102059 · Cited by 163 · see citing works
Cerda, A. A., & García, L. Y. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.626852 · Cited by 160 · see citing works
Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy
Reno, C., Maietti, E., Fantini, M. P., Savoia, E., Manzoli, L., Montalti, M., & Gori, D. (2021) · Vaccines · doi:10.3390/vaccines9040378 · Cited by 155 · see citing works
Mahmud, S. A. S., Mohsin, M., Khan, I. A., Mian, A. U., & Zaman, M. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257096 · Cited by 155 · see citing works
COVID-19: Rethinking the Lockdown Groupthink
Joffe, A. R. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.625778 · Cited by 153 · see citing works
Scannell, D., Desens, L., Guadagno, M., Tra, Y., Acker, E., Clay, K. S., Rosner, M., Mathieu, J. J., & Fulk, M. (2021) · Journal of Health Communication · doi:10.1080/10810730.2021.1955050 · Cited by 153 · see citing works
Correlates of COVID-19 vaccine hesitancy in Austria: trust and the government
Schernhammer, E. S., Weitzer, J., Laubichler, M. D., Birmann, B. M., Bertau, M., Zenk, L., Caniglia, G., Jäger, C. C., & Steiner, G. (2021) · Journal of Public Health · doi:10.1093/pubmed/fdab122 · Cited by 152 · see citing works
Rzymski, P., Borkowski, L., Drąg, M., Flisiak, R., Jemielity, J., Krajewski, J., Mastalerz–Migas, A., Matyja, A., Pyrć, K., Simon, K. A., et al. (2021) · Vaccines · doi:10.3390/vaccines9020109 · Cited by 151 · see citing works
Online Social Endorsement and Covid-19 Vaccine Hesitancy in the United Kingdom
Chadwick, A., Kaiser, J., Vaccari, C., Freeman, D., Lambe, S., Loe, B. S., Vanderslott, S., Lewandowsky, S., Conroy, M., Ross, A. R. N., et al. (2021) · Social Media + Society · doi:10.1177/20563051211008817 · Cited by 140 · see citing works
Alsanafi, M., & Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9070701 · Cited by 151 · see citing works
Wang, J., Lu, X., Lai, X., Lyu, Y., Zhang, H., Fenghuang, Y., Jing, R., Li, L., Yu, W., & Fang, H. (2021) · Vaccines · doi:10.3390/vaccines9030191 · Cited by 150 · see citing works
Hu, T., Wang, S., Luo, W. P., Zhang, M., Huang, X., Yan, Y., Liu, R., Ly, K., Kacker, V., She, B., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/30854 · Cited by 150 · see citing works
Montalti, M., Rallo, F., Guaraldi, F., Bartoli, L., Po, G., Stillo, M., Perrone, P., Squillace, L., Dallolio, L., Pandolfi, P., et al. (2021) · Vaccines · doi:10.3390/vaccines9040366 · Cited by 149 · see citing works
Al-Jayyousi, G. F., Sherbash, M., Ali, L. A. M., El‐Heneidy, A., Alhussaini, N. W. Z., Abdel‐Rahman, M. E., & Nazzal, M. A. (2021) · Vaccines · doi:10.3390/vaccines9060548 · Cited by 149 · see citing works
Rosen, B., Waitzberg, R., Israeli, A., Hartal, M., & Davidovitch, N. (2021) · Israel Journal of Health Policy Research · doi:10.1186/s13584-021-00481-x · Cited by 148 · see citing works
COVID-19 vaccination mandates and vaccine uptake
Karaivanov, A. K., Kim, D., Lu, S. E., & Shigeoka, H. (2022) · Nature Human Behaviour · doi:10.1038/s41562-022-01363-1 · Cited by 145 · see citing works
Kerr, J. R., Schneider, C. R., Recchia, G. L., Dryhurst, S., Sahlin, U., Dufouil, C., Arwidson, P., Freeman, A. L. J., & van der Linden, S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048025 · Cited by 143 · see citing works
Luo, C., Chen, A., Cui, B., & Liao, W. (2021) · Telematics and Informatics · doi:10.1016/j.tele.2021.101712 · Cited by 143 · see citing works
Umakanthan, S., Patil, S., Subramaniam, N., & Sharma, R. (2021) · Vaccines · doi:10.3390/vaccines9101064 · Cited by 143 · see citing works
RetractedChen, H., Li, X., Gao, J., Liu, X., Mao, Y., Wang, R., Zheng, P., Xiao, Q., Jia, Y., Fu, H., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/29329 · Cited by 142 · see citing works
Trust is the common denominator for COVID-19 vaccine acceptance: A literature review
Adhikari, B., Cheah, P. Y., & von Seidlein, L. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100213 · Cited by 141 · see citing works
- Authors
- Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., & El-Mohandes, A.
- Affiliations
- Barcelona Institute for Global Health (ES)
- City University of New York (US)
- Georgetown University (US)
- London School of Hygiene & Tropical Medicine (GB)
- Emerson College (US)
- Corresponding author
- Lazarus, Jeffrey V.
- ORCID
- Venue
- Nature Medicine
- Published
- 2020-10-20
- Volume
- 27
- Issue
- 2
- Pages
- 225-228
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC7573523
- OpenAlex
- W3093974194
- Semantic Scholar
- abe8c2a1c2a072c6c0f729204a329d82fffad38c
- Cited by
- 2,904
- References
- 19
- Citations by year
- 2026: 91 · 2025: 109 · 2024: 276 · 2023: 541 · 2022: 950 · 2021: 901 · 2020: 32 · 2018: 1
- FWCI
- 335.12
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-01-11)
- Open access
- bronze
- doi.org
- Locations
- Nature Medicine (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Scholarship - GEORGETOWN LAW (Georgetown University) (submittedVersion)
- SSRN Electronic Journal (submittedVersion)
- Funders
- City University of New York
- Ministerio de Ciencia, Innovación y Universidades (CEX 2018-000806-S)
- Centres de Recerca de Catalunya (CEX2018-000806-S)
- Generalitat de Catalunya (CEX2018-000806-S)
- Università Bocconi
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Sociology and Political Science › Risk Perception and Management
- Keywords
- COVID-19 vaccines, vaccine acceptance, vaccine hesitancy, vaccine confidence, public trust in government, cross-national comparison, vaccine attitudes
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Surveys and Questionnaires, Regression Analysis, Internationality, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review